Researchers found in Mallinckrodt documents a host of strategies that the pharma allegedly utilized to help sway doctors to prescribe its opioids.
As the Belgian pharma UCB recently inked a $1.9 billion deal to buy out Zogenix and its top drug for epilepsy, the company’s former controversial opioid has now been pulled from the market, according to a Federal Register filing by the FDA on Tuesday.
Enforcement Report - Week of December 15, 2021
In its first public safety alert in six years, the Drug Enforcement Administration is warning about a dramatic increase in fake prescription drugs being sold on the black market containing a potentially lethal dose of fentanyl.
The following quote is attributed to Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research
A study undertaken in Kazakhstan, Kyrgyzstan, Tajikistan and Ukraine has shown that training people most likely to witness an opioid overdose and providing them with naloxone, a drug that reduces the effects of overdose if administered rapidly, has the potential to significantly reduce the number of deaths in these countries if scaled up nationwide.
Alvogen Pink Brook`s Generic Hydrocodone Bitartrate Receives Approval In US
Alvogen Malta`s Generic Hydrocodone bitartrate Receives Approval in the U.S
Alvogen Pharma's Generic Hydrocodone bitartrate Receives Approval in U.S
Granules Pharms's Generic Hydrocodone Bitartrate and Acetaminophen Receives Approval In US